Teladoc Health, Inc.
Price Action
Technical Summary
CONSOLIDATINGTeladoc Health, Inc. is in a consolidation phase, trading with mixed signals as moving averages converge. Relative strength is leading (RS Rating: 88), indicating clear outperformance against the broad market. Earnings growth of 32% provides fundamental context to the price action. However, price is extended 30% above the 50-day line, increasing the risk of a mean reversion.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $7.67 | +18.58% | ABOVE |
| 50 SMA | $7.03 | +29.54% | ABOVE |
| 100 SMA | $6.11 | +48.89% | ABOVE |
| 150 SMA | $6.37 | +42.82% | ABOVE |
| 200 SMA | $6.81 | +33.66% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is TDOC in an uptrend right now?
TDOC has a trend score of 2/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 2 of 4 trend criteria are met.
Is TDOC overbought or oversold?
TDOC's RSI (14) is 67. The stock is in neutral territory, neither overbought nor oversold.
Is TDOC outperforming the market?
TDOC has a Relative Strength (RS) Rating of 88 out of 99. Yes, TDOC is a market leader, outperforming 88% of all stocks over the past 12 months.
Where is TDOC in its 52-week range?
TDOC is trading at $9.10, which is 93% of its 52-week high ($9.77) and 88% above its 52-week low ($4.40).
How volatile is TDOC?
TDOC has a Beta of 1.63 and 52-week volatility of 57%. It's more volatile than the S&P 500 - expect bigger swings.